Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines-Reference-Cited by-同舟云学术

Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines

Published:2018-08 Issue: Volume:69 Page:43-62
ISSN:2212-4926
Container-title:Advances in Biological Regulation
language:en
Short-container-title:Advances in Biological Regulation

Author:

Chappell William H.,Candido Saverio,Abrams Stephen L.,Russo Suzanne^ORCID,Ove Roger^ORCID,Martelli Alberto M.^ORCID,Cocco Lucio,Ramazzotti Giulia^ORCID,Cervello Melchiorre,Montalto Giuseppe,Steelman Linda S.,Leng Xiaohong,Arlinghaus Ralph B.,Libra Massimo,McCubrey James A.

Funder

Brody Brothers Foundation

ECU

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology,Molecular Medicine

Reference118 articles.

1. Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells;Abrams;Oncotarget,2017

2. p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism;Ak;Faseb. J.,2010

3. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB;Baldwin;J. Clin. Invest.,2001

4. Cancer of the prostate;Bracarda;Crit. Rev. Oncol.-Hematol.,2005

5. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB;Buontempo;Oncotarget,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MutS Homolog 2 and MutS Homolog 3 genes are equivocal in prostate disease diagnosis: A study from Niger Delta University Teaching Hospital (NDUTH) in Okolobiri, Bayelsa State, Nigeria;MED BALEAR;2024

2. Emphasizing the Role of Multi-omics Approach to Increase Survival Rate of Breast and Prostate Cancer Patients;Journal of Endocrinology and Reproduction;2023-09-12

3. The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer;Metabolites;2022-05-27

4. Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties;Aging;2022-04-27

5. Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue;Cancers;2022-03-25